Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

By S. Yusuf, S. Reddy, S. Ôunpuu, Sonia S Anand. Circulation, 2001

1,514 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Organizational Behavior and Human Resource Management

View Paper: https://www.semanticscholar.org/paper/51b75f699dd4b0fa4c7edea881e388e273a5df1a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. T. Horwich
2. Sonia S Anand
3. Richard J. Johnson
4. Roya Kelishadi
5. G. Fonarow
6. M. Salive

In Endocrinology, Diabetes and Metabolism

1. Richard J. Johnson
2. Roya Kelishadi
3. M. Salive

Citations in the corpus

• Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. (2003, background): “Furthermore, it should be noted that among many populations previously studied, levels of the classic vascular risk factors are suboptimally recognized and treated, and thus more emphasis should be placed on screening for and treating the conventional ASVD risk factors, given the proven value of tar”
• Childhood overweight, obesity, and the metabolic syndrome in developing countries. (2007, background): “The metabolic syndrome is highly prevalent in the adult population worldwide, with a suggested ethnic predisposition in Asians (4).”
• IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. (2005, background): “Thus, it could be speculated that the dramatic increase in CVD in developing countries could be partly related to this phenomenon [105].”
• Epidemiology and risk profile of heart failure (2010, background): “Although the magnitude of the HF burden in the developing world is not well quantified, enormous growth in the prevalence of HF is expected as developing countries shift from acute illness to chronic disease, the population ages, and the pervasiveness of HF risk factors, such as hypertension, corona”
• International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. (2006, background): “and further accelerate the impact of atherothrombosis on morbidity and mortality.(22-24)”
• Physical Activity and Risk of Cardiovascular Disease—A Meta-Analysis of Prospective Cohort Studies (2012, background): “Asian countries, respective evidence on protective effects of CVD produced by regular PA is badly needed [48-50].”